Dietary supplement recalled after lab analysis reveals it contains ingredients used in drugs for erectile dysfunction

Customers are told to stop using the product immediately and contact a doctor if they have experienced problems.
Norwalk Reflector Staff
Aug 22, 2013

Jack Rabbit Inc. announced today that it is conducting a voluntary nationwide recall of one lot of the company's dietary supplement product sold under the following name: Jack Rabbit.

The product was found to contain Sildenafil and Tadalafil. No illnesses have been reported to the company to date in connection with this product.

The company has been informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA for Lot 2510 found that the product contains sildenafil and Tadalafil.

Sildenafil and Tadalafil are active ingredients of FDA-approved drugs for erectile dysfunction (ED), making Jack Rabbit pack DIETARY SUPPLEMENT an unapproved drug. The active drug ingredients are not listed on the product label. The undeclared ingredients may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.

Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Additionally, the product may cause side effects, such as headaches and flushing.

Jack Rabbit Pack is marketed as a dietary supplement for sexual enhancement. It is packaged in 4 count blister packs and distributed online and retail stores nationwide.

Customers who have this product in their possession should stop using it immediately and contact their physician if they have experienced any problems that may be related to taking this product.

Consumers should return any unused product to the retail location where they were purchased or email Jack Rabbit, Inc. at JackRabbit4pack.com for a return address, 9 a.m. to 5 p.m. Monday through Friday.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s Medwatch Adverse Event Reporting Program either online, by regular mail or by fax.

Online; www.fda.gov/medwatch/report.htm

Regular mail: use postage-paid, pre-addressed form FDA 3500 available at: www.fda.gov/medwatch/getforms.htm. Mail to address on the pre-addressed form.

Fax: 1-800-fda-0178